BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Feb. 15, 2007
View Archived Issues
Halozyme Getting Up To $65M From Expanded Baxter Alliance
Halozyme Therapeutics Inc. significantly expanded its relationships with Baxter Healthcare Corp., continuing momentum at the company that gained full steam two months ago. (BioWorld Today)
Read More
Record Genzyme Revenues Clipped By AnorMED Buyout
Read More
Planning Pivotal MyoCell Trial, Bioheart Files For $35M IPO
Read More
Aging U.S. Population Is Fertile Ground For New Therapies
Read More
Current Orthopedic Strategies Complemented By Gene Therapy
Read More
GW Partners Sativex With Otsuka In Potential $273M Deal
Read More
Clinic Roundup
Read More
Other News To Note
Read More